Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Richardson PG, Larocca A, Lelu X. et al.
The burden of relapsed/refractory multiple myeloma: an indirect comparison of health-related quality of life burden across different types of advanced cancers at baseline and after treatment based on HORIZON (OP-106) study of melflufen plus dexamethasone.

Blood 2019;
134: 3487
DOI: 10.1182/blood-2019-124832.

Bibliographische Angaben herunterladen

Aufrufen in: